Regulation regarding glucocorticoids
With WADA's 2022 Prohibited List, the anti-doping rules for the use of glucocorticoids, also known as cortisone, have changed. Here you can find out what this might mean for you.
With WADA's 2022 Prohibited List, the anti-doping rules for the use of glucocorticoids, also known as cortisone, have changed. Here you can find out what this might mean for you.
Until 31/12/2021, glucocorticoids were prohibited in-competition when administered by oral, intravenous, intramuscular or rectal route.
With the WADA Prohibited List 2022 coming into effect as of 01/01/2022, all glucocorticoids are prohibited in competition when administered by any of the following routes:
Out-of-competition the routes of administration listed above are permitted. Please note the corresponding washout periods (see table below) that athletes should follow, expressed from the time of administration to the start of the in-competition period.
Glucocorticoids administered via other routes not mentioned above are permitted when used within the manufacturer´s licensed doses and therapeutic indications. These include the dermal (on the skin), inhaled, intranasal (in the nose), or ophthalmic (on the eye) application. With these types of application, it can be assumed that no high glucocorticoid concentrations are reached in the body.
To estimate the required interval between a glucocorticoid application and the next competition, WADA has published so-called washout periods.
Further information from WADA can be found in the document "Glucocorticoids and Therapeutic Use Exemptions".
The period commencing at 11:59 p.m. on the day before a competition in which the athlete is scheduled to participate through the end of such competition and the sample collection process related to such competition. Provided, however, WADA may approve, for a particular sport, an alternative definition.